Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2024

Emerging diagnostics and systemic treatments for patients with metastatic breast cancer (mBC)

Current treatment options for patients with metastatic triple-negative breast cancer (TNBC)

Date

07 Dec 2024

Session

Emerging diagnostics and systemic treatments for patients with metastatic breast cancer (mBC)

Presenters

Rebecca Dent

Authors

R.A. Dent

Author affiliations

  • Medical Oncology Department, NCCS - National Cancer Centre Singapore, 169610 - Singapore/SG

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Changing treatment landscape for HER2+ mBC

Presenter: Janice Wing-Hang Tsang

Session: Emerging diagnostics and systemic treatments for patients with metastatic breast cancer (mBC)

Resources:

Slides

Webcast

New treatment paradigms for HR+ / HER2- mBC

Presenter: Evandro de Azambuja

Session: Emerging diagnostics and systemic treatments for patients with metastatic breast cancer (mBC)

Resources:

Slides

Webcast

Q&A and discussion

Session: Emerging diagnostics and systemic treatments for patients with metastatic breast cancer (mBC)

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.